Carlyle(US:CG) Prnewswire·2026-01-27 19:00Core Insights - Resonetics has announced an agreement to acquire Resolution Medical, enhancing its capabilities in complex medical device design and manufacturing [1][2] - The acquisition is expected to close in 2026, pending regulatory approvals [2] Company Overview - Resolution Medical is based in Fridley, MN, and has operations in the Netherlands, currently owned by Arcline Investment Management [1] - The company employs over 240 individuals, including more than 100 engineers, and is recognized for its high-quality design engineering and cleanroom production capabilities [3] Strategic Benefits - The acquisition will add complementary capabilities in high-growth therapeutic markets such as neuromodulation, structural heart, and interventional cardiology [2][3] - Resonetics aims to become a comprehensive partner in the medical device industry by enhancing its ability to deliver integrated solutions [3] Operational Details - Until the transaction is finalized, both Resonetics and Resolution Medical will continue to operate independently [5] - Resonetics is backed by Carlyle and GTCR, providing end-to-end product development and manufacturing services [4]